Therapeutic Asset Ratings
3,774 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
TIL
Melanoma, Uveal
Udai Kammula
P2
CCC
(53)
TIL
Cutaneous Neuroendocrine Carcinoma
Udai Kammula
P2
CCC
(53)
TIL
Uveal Melanoma
Udai Kammula
P2
CCC
(53)
TIL
Microsatellite Instability
Udai Kammula
P2
CCC
(53)
TIL
Mismatch Repair Deficiency
Udai Kammula
P2
CCC
(53)
TIL
Skin Squamous Cell Carcinoma
Udai Kammula
P2
CCC
(53)
Tisagenlecleucel
Transformed Follic Lymph to Diff Large B-Cell Lymphoma
SWOG Cancer Research Network
P2
CCC
(53)
Whole Agonist-Stimulated T Cells
Non-Small Cell Lung Carcinoma
Tianjin Medical University Cancer Institute and Hospital
P2
CCC
(53)
Wztl-002 Car T-Cells
Diffuse Large B-Cell Lymphoma
Malaghan Institute of Medical Research
P2
CCC
(53)
Wztl-002 Car T-Cells
Primary Mediastinal Large B-Cell Lymphoma
Malaghan Institute of Medical Research
P2
CCC
(53)
Wztl-002 Car T-Cells
Non-Hodgkin Lymphoma
Malaghan Institute of Medical Research
P2
CCC
(53)
Young Til
Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Young Til
Adenosquamous Lung Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Young Til
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Young Til
Breast Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Young Til
Metastatic Endocrine Tumors/ Neuroendocrine Tumors
National Cancer Institute (NCI)
P2
CCC
(53)
Young Til
Ovarian Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Young Til
Squamous Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Zamtocabtagene Autoleucel
B-Cell Neoplasm
Miltenyi Biomedicine GmbH
P2
CCC
(53)
Zamtocabtagene Autoleucel
Primary Central Nervous System Lymphoma
Miltenyi Biomedicine GmbH
P2
CCC
(53)
Zamtocabtagene Autoleucel
High Grade B-Cell Lymphoma
Miltenyi Biomedicine GmbH
P2
CCC
(53)
Zamtocabtagene Autoleucel
Mantle Cell Lymphoma
Miltenyi Biomedicine GmbH
P2
CCC
(53)
Zamtocabtagene Autoleucel
Primary Mediastinal Large B-Cell Lymphoma
Miltenyi Biomedicine GmbH
P2
CCC
(53)
Zamtocabtagene Autoleucel
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Miltenyi Biomedicine GmbH
P2
CCC
(53)
Zamtocabtagene Autoleucel
Richter Transformation
Miltenyi Biomedicine GmbH
P2
CCC
(53)
Showing 401 to 425 of 3,774 assets
Previous
Page 17 of 151
Next